Abstract
In some years, the emerging leaves of white oak and, to a lesser extent, of red oak in the Midwest have developed abnormally. This abnormality is referred to as leaf tatters. Reports to state foresters and Extension specialists associated tatters with herbicide applications. In 2005, white and red oak seedlings were treated in a spray chamber delivering 187 L/ha, with seven herbicides at three concentrations, 1/4×, 1/10×, and 1/100× of the standard field use rate. These herbicides and their standard field use rate of the active ingredients included atrazine at 2.3 kg/ha and chloroacetanilide herbicides: acetochlor at 2.0 kg/ha, metolachlor at 2.1 kg/ha, and dimethenamid at 0.8 kg/ha alone or mixed with atrazine at 2.3 kg/ha, at the leaves unfolding stage. After treatment, oaks were placed outdoors in a randomized complete-block design. Leaf symptoms in our study were similar to those seen in the landscape. In chloroacetanilide-treated white and red oak seedlings, browning of interveinal leaf tissues was noticed 5–6 days after treatment. The dried leaf tissues then dropped off, leaving only the main vein with little interveinal leaf area. In few seedlings treated with atrazine, the leaf tissues turned yellow to brown, while in few others, interveinal tissue damage was restricted, leaving small holes in the leaf. When chloroacetanilide herbicides were applied with atrazine, the dominant symptoms were those of leaf tatters. A few seedlings treated with dimethenamid and atrazine had predominately atrazine symptoms. Although new growth later in the season was not injured, the leaves with tatters remained on the plant until the end of the growing season. The study will be repeated in 2006.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.